| Financial Year |
March 31 2023 |
| Monetary Funds |
10,070,952,149.69 |
| Held-for-trading Financial Assets |
1,573,062,698.60 |
| Notes Receivable |
645,061,821.03 |
| Accounts Receivable |
6,067,883,624.75 |
| Advances to Suppliers |
449,587,664.64 |
| Other Receivables |
812,900,090.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
14,300,600.00 |
| Inventories |
11,574,181,792.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,195,806,603.28 |
| Total Current Assets |
33,509,545,238.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,258,730,711.75 |
| Investment Properties |
1,163,129,728.13 |
| Fixed Assetes |
8,051,290,358.96 |
| Under-construction Projects |
2,831,372,393.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,468,708,123.99 |
| R&D expenses |
49,866,502.79 |
| Goodwill |
460,089,786.33 |
| Long-Term Deferred and Prepaid Expenses |
213,840,738.69 |
| Deferred Income Tax Assets |
537,076,823.78 |
| Other Non-Current Assets |
758,625,949.53 |
| Sub-Total of Non-Current Assets |
17,880,325,544.10 |
| Total Assets |
51,389,870,782.13 |
| Short-Term Loans |
6,657,890,346.84 |
| Trading Financial liabilities |
1,940,000.00 |
| Notes Payable |
2,852,631,909.19 |
| Accounts Payable |
6,647,031,489.77 |
| Accounts Received In Advance |
1,274,748.88 |
| Employee Compensation Payable |
381,605,433.01 |
| Taxes Payable |
420,271,640.77 |
| Interest Payable |
-- |
| Dividend Payable |
1,509,286.07 |
| Other payables |
670,226,734.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,182,425,806.10 |
| Other Current Liabilities |
43,261,686.40 |
| Sub-Total of Current Liabilities |
21,199,121,808.08 |
| Long-term Loans |
6,214,627,552.34 |
| Bonds Payable |
1,046,159,037.42 |
| Long-Term Accounts Payable |
1,286,426,157.65 |
| Special Payable |
-- |
| Estimatied Liabilities |
16,493,722.36 |
| Deferred Income Tax Liabilities |
309,784,842.60 |
| Other Non-Current Liabilities |
696,842,037.59 |
| Sub-Total of Non-Current Liabilities |
10,687,425,012.07 |
| Total Liabilities |
31,886,546,820.15 |
| Paid-In Capital(Or Share Stock) |
2,579,213,965.00 |
| Capital Surplus |
1,493,405,148.86 |
| Surplus Reserve |
328,964,842.92 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,055,046,951.18 |
| Minority Stockholder's Interest |
10,066,863,191.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,436,460,770.25 |
| Owner's Equity（Stockholder's Equity） |
19,503,323,961.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
51,389,870,782.13 |
